Safety and Efficacy of the Tong-Fu-Xing-Shen Herbal Formula for Stroke-Associated Pneumonia

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 218 participants.

Also called NCT04275219

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 218 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT04275219
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT04275219. Randomized; quadruple masking; primary purpose treatment. Start 2019-03-15 (actual); primary completion 2021-12 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Safety and Efficacy of the Tong-Fu-Xing-Shen Herbal Formula for Stroke-Associated Pneumonia
Acronym
TFXSHF
Condition
Stroke
Condition
Complication
Intervention (Drug)
Tongfu capsules
Intervention (Drug)
The Placebo of Tongfu capsules
Lead sponsor
Guangzhou University of Traditional Chinese Medicine (class: other)
Collaborator
People's Hospital of Ganzhou City (class: not stated)
Collaborator
People's Hospital of Lianjiang City (class: not stated)
Collaborator
Yangjiang Hospital of Traditional Chinese Medicine (class: not stated)
Collaborator
Shenyang No. 2 Hospital of Traditional Chinese Medicine (class: not stated)
Collaborator
Guangdong Provincial Hospital of Traditional Chinese Medicine (class: other)

Record details

Record id
cardio:ct-nct04275219
Content hash
65ea97165524396b8e362509d83616f76f8b37f104f6598959226e25bf525177